SAN DIEGO (AP) — Imprimis Pharmaceuticals Inc. (IMMY) on Thursday reported a loss of $2.8 million in its fourth quarter.
The San Diego-based company said it had a loss of 13 cents per share.
The pharmaceutical and drug compounding company posted revenue of $7.3 million in the period.
For the year, the company reported that its loss narrowed to $12 million, or 60 cents per share. Revenue was reported as $26.8 million.
In the final minutes of trading on Thursday, the company's shares hit $2.06. A year ago, they were trading at $2.39.